Jinxue Zhou

1.0k total citations
32 papers, 744 citations indexed

About

Jinxue Zhou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jinxue Zhou has authored 32 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Immunology. Recurrent topics in Jinxue Zhou's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Immune cells in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jinxue Zhou is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Immune cells in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jinxue Zhou collaborates with scholars based in China, United States and Canada. Jinxue Zhou's co-authors include Xingwang Xie, Lai Wei, Ran Fei, Gaixia He, Qingjun Li, Hongsong Chen, Henghui Zhang, Feng Han, Beibei Wang and Yaxian Kong and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Jinxue Zhou

31 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinxue Zhou China 16 326 274 271 220 94 32 744
Yongsheng Yang China 14 286 0.9× 199 0.7× 200 0.7× 157 0.7× 78 0.8× 27 642
Zehua Wang China 13 275 0.8× 126 0.5× 185 0.7× 187 0.8× 103 1.1× 32 562
Jufeng Guo China 17 373 1.1× 154 0.6× 204 0.8× 202 0.9× 87 0.9× 33 673
Haiyuan Shen China 13 412 1.3× 287 1.0× 233 0.9× 214 1.0× 89 0.9× 21 785
Chuanyong Zhang China 13 382 1.2× 125 0.5× 156 0.6× 231 1.1× 49 0.5× 25 630
Rong Su China 15 420 1.3× 350 1.3× 256 0.9× 238 1.1× 179 1.9× 44 951
Guang-Ang Tian China 13 324 1.0× 129 0.5× 166 0.6× 180 0.8× 93 1.0× 20 582
Jae Ho Lo United States 10 193 0.6× 159 0.6× 254 0.9× 92 0.4× 100 1.1× 29 547
Si Xiong China 16 473 1.5× 103 0.4× 362 1.3× 272 1.2× 75 0.8× 32 843

Countries citing papers authored by Jinxue Zhou

Since Specialization
Citations

This map shows the geographic impact of Jinxue Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxue Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxue Zhou more than expected).

Fields of papers citing papers by Jinxue Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinxue Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxue Zhou. The network helps show where Jinxue Zhou may publish in the future.

Co-authorship network of co-authors of Jinxue Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jinxue Zhou. A scholar is included among the top collaborators of Jinxue Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinxue Zhou. Jinxue Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shaoqing, Yanzhao Zhou, Fang Wu, et al.. (2025). PLAUR + Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment. Advanced Science. 12(38). e07167–e07167. 2 indexed citations
2.
Zhou, Yanzhao, Beilin Zhang, Ke Yang, et al.. (2025). Development of a circulating tumor DNA methylation biomarker panel for hepatocellular carcinoma detection. European Journal of Surgical Oncology. 52(1). 111167–111167. 1 indexed citations
3.
Li, Qingjun, Chang Xu, Yi Yang, et al.. (2025). Adjuvant Transarterial Chemoembolization in Resected Macrotrabecular-massive Hepatocellular Carcinoma (ATAC-MACRO): A Multicenter Real-world Retrospective Study. Academic Radiology. 32(5). 2585–2595. 1 indexed citations
4.
Wang, Baochen, Yanan Zhang, Yanzhao Zhou, et al.. (2024). Riboflavin kinase binds and activates inducible nitric oxide synthase to reprogram macrophage polarization. Redox Biology. 78. 103413–103413. 6 indexed citations
5.
Li, Zihan, et al.. (2024). Induction of MTHFD2 in Macrophages Inhibits Reactive Oxygen Species–mediated NF-κB Activation and Protects against Inflammatory Responses. The Journal of Immunology. 212(8). 1345–1356. 2 indexed citations
6.
Xü, Ying, Zhuo Li, Yanzhao Zhou, et al.. (2023). Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma. BMC Cancer. 23(1). 1009–1009. 4 indexed citations
7.
Shang, Man, Yan Cui, Penghui Hu, et al.. (2023). MTHFD2 reprograms macrophage polarization by inhibiting PTEN. Cell Reports. 42(5). 112481–112481. 18 indexed citations
8.
Xü, Ying, Zhuo Li, Yi Yang, et al.. (2023). Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance. Journal of Magnetic Resonance Imaging. 60(2). 715–728. 8 indexed citations
9.
Zhou, Yanzhao, Kun Yuan, Yi Yang, et al.. (2023). Gallbladder cancer: current and future treatment options. Frontiers in Pharmacology. 14. 1183619–1183619. 30 indexed citations
10.
Xü, Ying, Zhuo Li, Yi Yang, et al.. (2023). A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma. Insights into Imaging. 14(1). 173–173. 18 indexed citations
11.
Wang, Yunchao, Xiaobo Yang, Dongxu Wang, et al.. (2022). Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma. Frontiers in Oncology. 12. 785535–785535. 17 indexed citations
12.
13.
Wang, Jiaqi, et al.. (2017). Pulmonary sclerosing hemangioma with liver metastasis: report of one case and literature review. 6(1). 50–53. 1 indexed citations
14.
Wang, Yaohui, Jinxue Zhou, Wuhui Song, et al.. (2016). Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response. Tumor Biology. 37(11). 15265–15274. 9 indexed citations
15.
Cui, Hong, Feng Han, Ling Zhang, et al.. (2016). Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling. Oncology Letters. 12(2). 1471–1476. 37 indexed citations
16.
Zhou, Jinxue, Liang Zhou, Qingjun Li, et al.. (2016). Association between high levels of Notch3 expression and high invasion and poor overall survival rates in pancreatic ductal adenocarcinoma. Oncology Reports. 36(5). 2893–2901. 15 indexed citations
17.
He, Gaixia, Henghui Zhang, Jinxue Zhou, et al.. (2015). Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 141–141. 217 indexed citations
18.
Han, Feng, et al.. (2014). Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling. Pharmacological Reports. 67(2). 388–393. 44 indexed citations
19.
Chen, Yanhui, Weijia Liao, Jinxue Zhou, et al.. (2013). FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China. Journal of Experimental & Clinical Cancer Research. 32(1). 39–39. 34 indexed citations
20.
Zhou, Jinxue, Yin Li, Sunxiao Chen, & Anmei Deng. (2011). Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma. Journal of Experimental & Clinical Cancer Research. 30(1). 2–2. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongsheng Yang Breakdown of academic impact, for papers by Zehua Wang Breakdown of academic impact, for papers by Jufeng Guo Breakdown of academic impact, for papers by Haiyuan Shen Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Rong Su Breakdown of academic impact, for papers by Guang-Ang Tian Breakdown of academic impact, for papers by Jae Ho Lo Breakdown of academic impact, for papers by Si Xiong
Rankless by CCL
2026